Alector, Inc.

ALEC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $65.8M $33.0M $74.6M $154.3M $329.2M $50.0M $89.6M $65.5M
Accounts Receivable
Inventory
Total Current Assets $266.5M $424.8M $565.8M $726.4M $749.7M $421.5M $357.4M $293.2M
Property, Plant & Equipment $10.8M $17.1M $21.9M $25.5M $27.3M $30.2M $33.9M $10.9M
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $293.2M $468.3M $621.8M $787.6M $814.7M $488.3M $421.9M $308.4M
Liabilities
Accounts Payable $1.7M $2.2M $3.8M $4.2M $4.7M $3.0M $278.0K $126.0K
Total Current Liabilities $69.5M $125.1M $177.9M $93.8M $139.6M $68.1M $62.0M $47.9M
Long-Term Debt $9.3M $9.4M $0
Total Liabilities $262.6M $341.5M $487.7M $573.2M $513.9M $220.7M $227.2M $195.2M
Stockholders' Equity
Retained Earnings $-972.1M $-829.1M $-710.1M $-579.7M $-446.4M $-410.0M $-219.8M $-114.4M
Total Stockholders' Equity $30.6M $126.8M $134.2M $214.4M $300.7M $267.5M $194.7M $-97.4M
← Newer Page 1 of 2 Older →